Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. follow up treatment
Show results for
Products
Services
Applications

Companies

News
Articles

Refine by
Date

  • Older

Follow Up Treatment Articles & Analysis: Older

7 news found

Fractyl Health Publishes Two-Year Durability Data After a Single Revita DMR Therapeutic Procedure in Patients with Type 2 Diabetes

Fractyl Health Publishes Two-Year Durability Data After a Single Revita DMR Therapeutic Procedure in Patients with Type 2 Diabetes

In the cohort followed through two years, HbA1c was observed to be statistically significantly reduced at all time points, as were broader measures of metabolic control, including reductions in weight and improvements in patient self-reported diabetes treatment satisfaction questionnaires (DTSQc). ...

ByFractyl Health


Kadimastem Announces the Approval of a 4M NIS ($1.29M) Budget from the Israel Innovation Authority

Kadimastem Announces the Approval of a 4M NIS ($1.29M) Budget from the Israel Innovation Authority

As Kadimastem intends to submit the IND for the Phase IIa clinical study before the end of 2022, the IIA funding will be used to scale up the production of a frozen, off-the-shelf product of AstroRx® in preparation for the trial. ...

ByKadimastem Ltd.


Lyra Therapeutics Presents New Positive Phase 2 LANTERN 6-Month Follow-Up and LYR-210 Pharmacokinetic Data, and LANTERN Manuscript Wins Award at the 67th Annual Meeting of the American Rhinologic Society

Lyra Therapeutics Presents New Positive Phase 2 LANTERN 6-Month Follow-Up and LYR-210 Pharmacokinetic Data, and LANTERN Manuscript Wins Award at the 67th Annual Meeting of the American Rhinologic Society

LYR-210 is highly convenient to administer and remove in a routine office visit and has the potential to provide an impactful treatment option for a broad CRS patient population." "The LANTERN follow-up and PK data presented at ARS underscore our belief in LYR-210's potential to disrupt the CRS treatment landscape for the ...

ByLyra Therapeutics, Inc.


U.S. Food and Drug Administration Clears UVision360, Inc. Novel LUMINELLE® 360° Bx (Biopsy) Sheath

U.S. Food and Drug Administration Clears UVision360, Inc. Novel LUMINELLE® 360° Bx (Biopsy) Sheath

Taking directed tissue samples helps doctors and patients and arrange for follow up treatment sooner rather than later. A patient can have increased confidence in their diagnosis while the simplicity of the equipment makes the procedure more convenient and less challenging for the physician. ...

ByLUMINELLE


REDUCE FMR Study Shows Cardiac Dimensions’ Carillon System Significantly Improves Mitral Regurgitation and Slows Worsening of Heart Failure

REDUCE FMR Study Shows Cardiac Dimensions’ Carillon System Significantly Improves Mitral Regurgitation and Slows Worsening of Heart Failure

“Carillon provides an option to treat a large portion of FMR patients with a minimally-invasive treatment that doesn’t compromise the valve leaflets. Patients across a wide spectrum of MR grade and NYHA class benefited from Carillon treatment, experiencing significant improvements in MR and favorable remodeling of the left ventricle. ...

ByCardiac Dimensions, Inc.


Surgivisio launches pediatric app

Surgivisio launches pediatric app

Less radiant, this system is in line with our efforts to reduce children's exposure to X-rays during the follow-up and treatment of scoliosis. Protected by over thirty patents, Surgivisio’s technology enabled the company to win phases 1, 2 and 3 of the World Innovation Challenge, and to benefit from an investment in 2018 of 10.7 million ...

ByeCential Robotics


QIAGEN HPV DNA test donation to expand access to cervical cancer screening for women in rural India

QIAGEN HPV DNA test donation to expand access to cervical cancer screening for women in rural India

Rengaswamy Sankaranarayanan, was designed to assess the effectiveness of various cervical cancer screening technologies in reducing cervical cancer incidence and death rates. Following the April 2009 publication of study results in The New England Journal of Medicine, QIAGEN announced a donation of one million HPV tests to low-income countries over five years. ...

ByCSRwire - Corporate Social Responsibility Newswire

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT